The Joint (JYNT) Sees 3.6% Price Movement on Below Average Volume

By Kim Brooks • Wednesday, July 19 11:42 • Permanent Link

The Joint stock is trading -53.38% below its average target price of $29.9 after marking a 3.6% during today's morning session. Analysts are giving the small-cap Medical Care Facility company an average rating of buy and target prices ranging from $15.5 to $50.0 per share.

The Joint has an average level of shares sold short, at 8.2% of its total share float. The stock's short ratio (also called days to cover) is 11.38. At 1.37%, the company's rate of insider ownership does not indicate that management is deeply invested in the company.

Institutional investors own 93.1% of The Joint's shares, which indicates they have a high level of confidence in the company.

Institutions Invested in The Joint

Date Reported	Holder	Percentage	Shares	Value
2023-03-31	Bandera Partners LLC	18%	2,599,151	$36,232,163
2023-03-31	Blackrock Inc.	7%	988,802	$13,783,899
2023-03-31	Vanguard Group Inc	6%	942,471	$13,138,045
2023-03-31	Millennium Management Llc	5%	721,416	$10,056,538
2023-03-31	Federated Hermes, Inc.	3%	461,396	$6,431,860
2023-03-31	Skylands Capital, LLC	3%	427,090	$5,953,634
2023-03-31	Shaw D.E. & Co., Inc.	3%	393,841	$5,490,143
2023-03-31	Morgan Stanley	2%	360,037	$5,018,915
2023-03-31	Goldman Sachs Group Inc	2%	334,654	$4,665,076
2023-03-31	Deutsche Bank Aktiengesellschaft	2%	302,772	$4,220,641

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.